Huitt Tracey
Vermogen: 22 300 $ op 30-09-2026
Vermogen: 22 300 $ op 30-09-2026
Mr. Huitt Tracey is an Independent Director at Black Pine Resources Corp., an Independent Director at Iconic Minerals Ltd. and a Head-Investor Relations at NervGen Pharma Corp.
He is on the Board of Directors at Black Pine Resources Corp.
and Iconic Minerals Ltd. Mr. Tracey was previously employed as an Independent Director by Anquiro Ventures Ltd. and an Independent Director by Curlew Lake Resources, Inc. He also served on the board at Quantum Solar Power Corp.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,98% | 13-08-2026 | 300.000 ( 0,98% ) | 18 000 $ | 30-09-2026 |
ICONIC MINERALS LTD 0,05% | 02-04-2026 | 100.000 ( 0,05% ) | 4 300 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ICONIC MINERALS LTD. | Directeur/Bestuurslid | 23-07-2014 |
| NERVGEN PHARMA CORP. | Investor Relations Contact | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| C21 INVESTMENTS INC. | Directeur/Bestuurslid | 18-06-2015 |
| QUANTUM SOLAR PWR | Directeur/Bestuurslid | 16-07-2010 |
| BLACK PINE RESOURCES CORP. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Iconic Minerals Ltd.
Iconic Minerals Ltd. Chemicals: AgriculturalProcess Industries Explores lithium projects | Process Industries |
C21 Investments, Inc.
C21 Investments, Inc. Agricultural Commodities/MillingProcess Industries Engages in cultivation, processing and distribution of cannabis | Process Industries |
Quantum Solar Power Corp.
Quantum Solar Power Corp. Electric UtilitiesUtilities Develops and commercializes solar power technology | Utilities |
Anquiro Ventures Ltd.
Anquiro Ventures Ltd. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
NervGen Pharma Corp.
NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau